- Dit evenement is voorbij.
Molecule2Business 2022
29 september 2022 @ 13:00 - 18:00
Development of new medicines is a lengthy and laborious process. The time it takes from initial discovery of a working molecule to treating a patient is more than 10 years and more than 2,5 billion dollars. Just the clinical phase takes up more than 7 years in this process.
At this moment there are a lot of new approaches to speeding up the development process of new drugs. From parallelization of development, AI to select the best candidates, organs on a chip or even detailed digital twins to calculate the effects of molecules on humans before they are really applied in reality.
The Molecule2Business 2022 event will dive into new approaches to speed up the process of bringing new pharmaceuticals to the market.
With keynotes from:
Prof. Dr. Hub Zwart was a member of the ethic committee of the European lead factory and is currently appointed as dean of Erasmus School of Philosophy.
Thijs Merkx is chairman of the executive board of IKNL since December 2019 and professor of oral and maxillofacial oncology and oral medicine at Radboudumc since 2008.
And parallel sessions on the state of art in the different stages of drugs development (discovery, pre-clinical, clinical and pharmacovigilance).
More information and names of more presenters will follow soon!
Program:
13.00u Walk-in
13.30u Opening event
17.00u Start networking
18.00u End meeting
Live event
Our partners and organisers Briskr, Health Valley, Pivot Park & SMB aim to organize this workshop in a live setting and will take all necessary RIVM/national measures into account. If a physical workshop is not possible, we will reschedule to a later date or convert to online.
This workshop is free of charge and facilitated in English.